The cannabis sector is one that most investors would probably describe as a former bubble. But today, with valuations coming ...

This comes at a time when cannabis use among boomers is, well, booming. The number of Americans aged 65+ using cannabis for medical purposes rose from 4.8% in 2021 to 7% in 2023, a 46% jump in just ...

Canopy Growth › Buying a stock for a mere $2 may sound cheap on the surface, but that's only the case if there are good ...

In December, President Donald Trump in an executive order told his attorney general to expediate a rulemaking process related to rescheduling marijuana as a less-dangerous drug.

Recent regulatory developments have improved the landscape of the cannabis industry in the U.S. Canopy Growth and Aurora ...

U.S. cannabis stocks appear to have completed their post-Executive Order pullback, says Beacon Securities analyst Russell ...

Beacon Securities analyst Russell Stanley said in a January 15 industry update that the post-correction recovery in U.S.

Many cannabis stocks have experienced significant growth over the past six months. For instance, shares of Tilray Brands ...

When speculation broke out that President Donald Trump could move to reschedule marijuana as a Schedule III drug before the ...

Dec 18 (Reuters) - Shares of some cannabis firms fell between 3% and 12% at Thursday's close, erasing previous gains from the session, after U.S. President Donald Trump signed an executive order ...